Laboratory News and Research

RSS

The most recent evidence about phylogenesis, pathogenesis, prevention, and treatment for monkeypox

A new review sheds light on the origins of this virus and recently acquired knowledge about its disease mechanism and the preventive and therapeutic measures appropriate in this situation.

31 Aug 2022

Moffitt study uses computer modeling to demonstrate the impact of skin homeostasis on driver and passenger mutations

All normal human tissues acquire mutations over time. Some of these mutations may be driver mutations that promote the development of cancer through increased proliferation and survival, while other mutations may be neutral passenger mutations that have no impact on cancer development.

30 Aug 2022

Research provides a major step forward to growing human kidney in a dish

Kidney disease affects one in nine adults globally and the incidence of kidney failure is steadily rising around the world.

30 Aug 2022

Italian study finds SARS-CoV-2 in clinical samples collected before December 2019

Researchers discuss the association of SARS-CoV-2 with morbilliform skin rash and confirms viral circulation in September 2019.

30 Aug 2022

New treatment may be effective in addressing the long-term effects of preeclampsia

Preeclampsia is a condition that affects the placenta during pregnancy and is dangerous for both the fetus and the mother.

30 Aug 2022

Researchers identify potential new pathway for treating a sporadic form of ALS

Researchers have published two papers describing how they identified a potential new pathway for treating a sporadic form of amyotrophic lateral sclerosis (ALS).

30 Aug 2022

Researchers demonstrate a pneumatic hand made using a commercial 3D printer

Artificial pneumatic muscles consisting of 3D-printed structures that can extend and contract as required: this is the innovative design of the GRACE actuators devised by researchers from the Istituto Italiano di Tecnologia (IIT, Italian Institute of Technology) in Genoa and the Scuola Superiore Sant'Anna (SSSA, Sant'Anna School of Advanced Studies) in Pisa.

30 Aug 2022

COVID-19 may provoke IgA-associated vasculitis

In a new study, scientists showed that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection provokes immunoglobulin A (IgA)-associated vasculitis (IgAV).

30 Aug 2022

Research reveals administration of ineffective COVID-19 treatments after FDA deauthorization

Monoclonal antibodies are laboratory-designed treatments tailor-made to fight specific infections. In early 2021, the U.S. Food & Drug Administration issued emergency use authorization for two monoclonal antibodies (bamlanivimab/etesevimab and casirivimab/imdevimab) for the treatment of mild to moderate COVID-19 in high-risk, non-hospitalized patients.

30 Aug 2022

Disrupting a virus’s genome packaging can halt replication, study finds

Like savvy international travelers, viruses know exactly how to pack. With the genetic instructions for the next generation folded just so, snuggled into a custom-made outer covering studded with cell-grabbing proteins, these tiny invaders quest for new digs on the reg.

30 Aug 2022

3 shots in 1: How microparticles could be used to deliver self-boosting vaccines

In this interview, we speak to Morteza Sarmadi from MIT about his labs latest research that developed microparticles able to deliver self-boosting vaccines.

30 Aug 2022

Discovery paves the way for specific therapies for common form of childhood brain and spine tumor

A study conducted by researchers in Brazil, Australia, Austria and the United States has made significant discoveries about a type of pediatric cancer with no approved drugs for treatment and with a low survival rate.

29 Aug 2022

Study moves one step closer to providing a more efficient treatment for age-related memory loss

According to the Alzheimer's Association, an estimated 6.5 million Americans aged 65 and older are living with Alzheimer's in 2022. That figure is predicted to nearly double by 2050.

29 Aug 2022

Implanted brain-stimulating device disrupts craving-related signals and reduces bingeing episodes

A small device that detects food craving-related brain activity in a key brain region, and responds by electrically stimulating that region, has shown promise in a pilot clinical trial in two patients with loss-of-control binge eating disorder (BED), according to researchers at the Perelman School of Medicine at the University of Pennsylvania.

29 Aug 2022

TTUHSC scientist receives U.S. patent to produce novel nanoantibiotics

According to the Centers for Disease Control and Prevention, more than 2.8 million Americans contract antibiotic-resistant bacterial infections each year, and approximately 35,000 of those patients do not survive their infection.

29 Aug 2022

EPFL scientists uncover key mechanisms underlying the formation of protein tangles in the brain

Neurodegenerative disorders such as Alzheimer's and Parkinson's disease are associated with atypical proteins that form tangles in the brain, killing neurons.

29 Aug 2022

Novel method for accurate diagnosis and treatment of uveitis

An estimated five to ten percent of blindness worldwide is caused by the rare inflammatory eye disease uveitis. Posterior uveitis in particular is often associated with severe disease progression and the need for immunosuppressive therapy.

29 Aug 2022

The clinical and virological outcomes associated with molnupiravir or nirmatrelvir–ritonavir use in hospitalized patients with mild-to-moderate COVID-19

Researchers investigated whether early treatment with oral antivirals prevented all-cause mortality in hospitalized patients infected with SARS-CoV-2 new variant of concern Omicron BA.2 subvariant.

29 Aug 2022

Protection against SARS-CoV-2 reinfections in the Qatari population

Researchers evaluated protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection.

29 Aug 2022

Research characterizes clinical and epidemiologic features of SARS-CoV-2 in pets

Researchers analyze the clinical and epidemiological features of SARS-CoV-2 infection in dogs and cats in the United States.

28 Aug 2022

Laboratory News and Research

The most recent evidence about phylogenesis, pathogenesis, prevention, and treatment for monkeypox

Moffitt study uses computer modeling to demonstrate the impact of skin homeostasis on driver and passenger mutations

Research provides a major step forward to growing human kidney in a dish

Italian study finds SARS-CoV-2 in clinical samples collected before December 2019

New treatment may be effective in addressing the long-term effects of preeclampsia

Researchers identify potential new pathway for treating a sporadic form of ALS

Researchers demonstrate a pneumatic hand made using a commercial 3D printer

COVID-19 may provoke IgA-associated vasculitis

Research reveals administration of ineffective COVID-19 treatments after FDA deauthorization

Disrupting a virus’s genome packaging can halt replication, study finds

3 shots in 1: How microparticles could be used to deliver self-boosting vaccines

Discovery paves the way for specific therapies for common form of childhood brain and spine tumor

Study moves one step closer to providing a more efficient treatment for age-related memory loss

Implanted brain-stimulating device disrupts craving-related signals and reduces bingeing episodes

TTUHSC scientist receives U.S. patent to produce novel nanoantibiotics

EPFL scientists uncover key mechanisms underlying the formation of protein tangles in the brain

Novel method for accurate diagnosis and treatment of uveitis

The clinical and virological outcomes associated with molnupiravir or nirmatrelvir–ritonavir use in hospitalized patients with mild-to-moderate COVID-19

Protection against SARS-CoV-2 reinfections in the Qatari population

Research characterizes clinical and epidemiologic features of SARS-CoV-2 in pets

A guide to density measurement excellence eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo